Меню
Набор по приглашению NCT07293624

Effects of the Dietary Inflammatory Index on Systemic Inflammation Markers and Gastrointestinal Symptoms in Individuals With Bariatric Surgery

Наблюдательное Bariatric Surgery Bariatric Sleeve Gastrectomy Inflamation Systemic Inflammation

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Observational Intervention, Observetional.
Кому может быть актуально
Состояния в реестре: Bariatric Surgery, Bariatric Sleeve Gastrectomy, Inflamation, Systemic Inflammation. Базовые параметры: 18 лет — 65 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Turkey (Türkiye)
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →

Обзор

The goal of this observational cross-sectional study is to evaluate the relationships between the Dietary Inflammatory Index (DII), systemic inflammatory markers, and gastrointestinal symptoms in adults aged 18-65 who have undergone bariatric surgery. The main questions it aims to answer are: Does the inflammatory potential of the diet affect systemic inflammation levels (such as SII, CRP, and WBC) in the post-operative period? Is there an association between the DII score and gastrointestinal symptoms (e.g., bloating, gas, abdominal pain)? Participants who are at least three months post-bariatric surgery will provide dietary intake data to calculate DII scores, undergo blood tests to measure inflammatory markers, and complete assessments regarding their gastrointestinal symptoms.

Вмешательства

  • Другое Observational Intervention
    This is cross sectional observational study.
  • Другое Observetional
    This is cross-sectional study. Questionnaire, Dietary Inflammatory Index (DII), systemic inflammatory markers, and gastrointestinal symptoms will be investigated.

Первичные конечные точки

  • Biochemical Measurements - Fasting blood glucose [Срок оценки: at the beginning the study 1 times]
  • Biochemical Measurement - Lipid Profile [Срок оценки: at the beginning the study 1 times]
  • Biochemical Measurements - Liver Enzymes [Срок оценки: at the beginning the study 1 times]
  • Biochemical Measurements - CRP [Срок оценки: at the beginning the study 1 times]
  • Anthropometric Measurements - Body weight (kg) [Срок оценки: at the beginning the study 1 times]
  • Anthropometric Measurements - Height [Срок оценки: at the beginning the study 1 times]
  • Body Mass Index [Срок оценки: at the beginning the study 1 times]
  • Body Mass Index Classification [Срок оценки: at the beginning the study 1 times]
  • Anthropometric Measurements - Fat Mass [Срок оценки: at the beginning the study 1 times]
  • Anthropometric Measurements - Fat ratio calculation [Срок оценки: at the beginning the study 1 times]
Вторичные конечные точки (5)
  • Food Consumption Record [Срок оценки: 3 days]
  • Food Consumption Record [Срок оценки: 3 days]
  • Food Consumption Record [Срок оценки: 3 days]
  • Bristol Stool Form Scale [Срок оценки: at the beginning of the study]
  • Gastrointestinal Symptom Assessment Scale [Срок оценки: at the beginning of the study]

Критерии участия

Критерии включения

  • Adult individuals between the ages of 18 and 65,
  • Having undergone bariatric surgery at least 3 months prior,
  • Individuals who agreed to participate voluntarily in the study and signed the informed consent form,
  • Having the cognitive ability/literacy to completely complete the food consumption record and questionnaire forms,
  • Individuals with no health conditions that would prevent blood tests,
  • Individuals who were regularly followed up after surgery and had no postoperative complications.

Критерии исключения

  • Individuals diagnosed with gastrointestinal diseases such as inflammatory bowel disease, celiac disease, or short bowel syndrome before or after bariatric surgery,
  • Those with a history of diseases that could affect systemic inflammation, such as autoimmune disease, active infection, or cancer,
  • Individuals regularly taking medications that could affect inflammation levels, such as corticosteroids, immunosuppressants, or anti-inflammatory drugs,
  • Individuals actively or recently using probiotic supplements,
  • Pregnant or breastfeeding women,
  • Those with a history of chronic alcohol use or substance abuse,
  • Individuals who experienced serious postoperative complications after surgery (e.g., anastomotic leak, serious infection, or conditions requiring reoperation),
  • Individuals with cognitive or communication disabilities that prevented them from providing the necessary information and data to the study or who were lost to follow-up,
  • Individuals with chronic organ failure,
  • Individuals with a psychiatric diagnosis,
  • Individuals who did not consent to their data being used for scientific purposes.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Модель наблюдения
Другое

Центры проведения

Turkey (Türkiye) · 1 центр
  • Istanbul Bilgi University — Istanbul

Идентификаторы

NCT: NCT07293624 · BARINFLAMMATION

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗